Is Retatrutide FDA-Approved Yet? Current Status
FAQ-000062
Direct Answer
No, retatrutide is not yet FDA-approved as of this writing. It remains an investigational medication, currently in Phase 3 clinical trials under Eli Lilly's TRIUMPH program. There is no confirmed public FDA decision date. It is not available by prescription, and it cannot legally be obtained outside of clinical trial enrollment.
Where It Stands in the Approval Process
Phase 3 is the final stage of clinical testing before a manufacturer can submit a New Drug Application to the FDA. Once submitted, the FDA typically takes several months to a year or more to review an application before issuing a decision. As of this writing, no New Drug Application submission date has been publicly confirmed for retatrutide.
Why This Page Exists
Given real, ongoing search interest in this exact question, and given how much confusion exists around the informal "GLP-3" nickname, this page exists specifically to give a clear, current, accurate answer, checked and updated as retatrutide's real regulatory status changes.
What to Watch For
An FDA approval decision for a medication this significant would be major news, covered immediately by financial and health media given Eli Lilly's public company status. If and when a decision occurs, this page will be updated to reflect it.
References
- Eli Lilly and Company: TRIUMPH Phase 3 Program
Related Resources
Related Articles
Track It Directly
Visit the GLP-3 Tracker to start logging retatrutide alongside your other GLP-1 medications.
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 and investigational medication.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Regulatory status can change; this page is checked and updated as new, confirmed information becomes available. This article is for general informational purposes and is not medical advice.
is-retatrutide-fda-approved-yet